1.
Ann Oncol
; 27(7): 1354-6, 2016 07.
Article
in English
| MEDLINE
| ID: mdl-27037297
Subject(s)
Antibodies, Monoclonal/adverse effects , Antineoplastic Agents/adverse effects , Brain Neoplasms/drug therapy , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , Severity of Illness Index , Aged , Aged, 80 and over , Brain Neoplasms/diagnosis , Brain Neoplasms/secondary , Carcinoma, Non-Small-Cell Lung/chemically induced , Carcinoma, Non-Small-Cell Lung/diagnosis , Female , Humans , Lung Neoplasms/chemically induced , Lung Neoplasms/diagnosis , Male , Middle Aged , Nivolumab
2.
Kekkaku
; 57(12): 643-51, 1982 Dec.
Article
in Japanese
| MEDLINE
| ID: mdl-6763648
3.
Kekkaku
; 49(2): 23-5, 1974 Feb.
Article
in Japanese
| MEDLINE
| ID: mdl-4827969
Subject(s)
Tuberculosis/drug therapy , Animals , Antitubercular Agents/therapeutic use , Humans , Time Factors
4.
Kekkaku
; 48(2): 23, 1973 Feb.
Article
in Japanese
| MEDLINE
| ID: mdl-4571336
Subject(s)
Spleen/immunology , Tuberculosis/immunology , Animals , Male , Mice , Mycobacterium bovis/immunology
5.
Kekkaku
; 46(2): 2, 1971 Feb.
Article
in Japanese
| MEDLINE
| ID: mdl-5549794